Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1
暂无分享,去创建一个
A. Regev | Dariusz Przybylski | Youjin Lee | V. Kuchroo | R. Sobel | Chao Wang | A. Schnell | M. Schramm | Gerd Meyer zu Horste | Alexandra Schnell
[1] Yuka Kanno,et al. Mechanisms and consequences of Jak–STAT signaling in the immune system , 2017, Nature Immunology.
[2] T. Korn,et al. T cell responses in the central nervous system , 2017, Nature Reviews Immunology.
[3] A. Regev,et al. RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression. , 2016, Cell reports.
[4] M. Veldhoen,et al. Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology , 2016, The Journal of Immunology.
[5] Youjin Lee,et al. IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis. , 2015, The Journal of clinical investigation.
[6] V. Kuchroo,et al. IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling , 2015, The Journal of Immunology.
[7] Rona S. Gertner,et al. Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity , 2015, Cell.
[8] Y. Okamoto,et al. Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity. , 2015, Immunity.
[9] D. Centonze,et al. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients , 2015, Cell Death and Disease.
[10] Judith A. Blake,et al. The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease , 2014, Nucleic Acids Res..
[11] Mark S. Sundrud,et al. Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. , 2014, Immunity.
[12] E. Bettelli,et al. Cutting Edge: The Pathogenicity of IFN-γ–Producing Th17 Cells Is Independent of T-bet , 2013, The Journal of Immunology.
[13] A. Regev,et al. Dynamic regulatory network controlling Th17 cell differentiation , 2013, Nature.
[14] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[15] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[16] A. Fischer,et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.
[17] O. Janssen,et al. Modulation of CD4+ T-cell activation by CD95 co-stimulation , 2011, Cell Death and Differentiation.
[18] M. Veldhoen,et al. Fate mapping of interleukin 17-producing T cells in inflammatory responses , 2011, Nature Immunology.
[19] Todd Davidson,et al. Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.
[20] N. Friedman,et al. Comprehensive comparative analysis of strand-specific RNA sequencing methods , 2010, Nature Methods.
[21] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[22] W. Paul,et al. Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.
[23] W. Paul,et al. Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.
[24] V. Kuchroo,et al. Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1 , 2009, The Journal of Immunology.
[25] Lionel B Ivashkiv,et al. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.
[26] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[27] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[28] A. Strasser,et al. The many roles of FAS receptor signaling in the immune system. , 2009, Immunity.
[29] B. Becher,et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. , 2008, The Journal of clinical investigation.
[30] Warren Strober,et al. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells , 2008, Nature Immunology.
[31] S. Tangye,et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.
[32] W. Paul,et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.
[33] Hua Yu,et al. Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1 , 2007, The Journal of Immunology.
[34] D. G. Zisoulis,et al. Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells1 , 2007, The Journal of Immunology.
[35] Chen Dong,et al. STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells* , 2007, Journal of Biological Chemistry.
[36] V. Kuchroo,et al. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. , 2006, The Journal of clinical investigation.
[37] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[38] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[39] Alexander E. Kel,et al. TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..
[40] R. Budd,et al. The Death Receptor Fas (CD95/APO-1) Mediates the Deletion of T Lymphocytes Undergoing Homeostatic Proliferation1 , 2005, The Journal of Immunology.
[41] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[42] F. Rieux-Laucat,et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. , 2004, The New England journal of medicine.
[43] S. Szabo,et al. Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.
[44] K. Rajewsky,et al. T Cell–specific Ablation of Fas Leads to Fas Ligand–mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis , 2004, The Journal of experimental medicine.
[45] H. Weiner,et al. Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis , 2003, The Journal of experimental medicine.
[46] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[47] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[48] Ye Zheng,et al. NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.
[49] Y. E. Chin,et al. Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.
[50] T. Owens,et al. IFN-γ Shapes Immune Invasion of the Central Nervous System Via Regulation of Chemokines1 , 2000, The Journal of Immunology.
[51] J. Tschopp,et al. Caspase Activation Is Required for T Cell Proliferation , 1999, The Journal of experimental medicine.
[52] A. Chinnaiyan,et al. A role for FADD in T cell activation and development. , 1998, Immunity.
[53] A. Cross,et al. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. , 1997, Journal of immunology.
[54] V. Kuchroo,et al. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. , 1997, Journal of immunology.
[55] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[56] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[57] K. Honda,et al. The contribution of transcription factor IRF1 to the interferon-γ–interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells , 2008, Nature Immunology.
[58] Jianfei Yang,et al. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells , 2002, Nature Immunology.
[59] S. Gerondakis,et al. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. , 2001, Journal of immunology.
[60] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[61] V. Kuchroo,et al. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. , 2004, The Journal of clinical investigation.
[62] R. Tsien,et al. Specificity and Stability in Topology of Protein Networks , 2022 .